Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (11) , 1682-1688
- https://doi.org/10.1016/j.ejca.2004.03.008
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07Journal of Clinical Oncology, 2003
- A multicenter study of treatment of primary CNS lymphomaNeurology, 2002
- German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphomaAnnals of Neurology, 2002
- Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trialsAnnals of Oncology, 2000
- Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of PatientsJournal of Neuro-Oncology, 1999
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Short Intensive Primary Chemotherapy and Radiotherapy in Sporadic Primary CNS Lymphoma (PCL)International Journal of Radiation Oncology*Biology*Physics, 1998
- Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literatureAnnals of Oncology, 1997
- Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.Journal of Clinical Oncology, 1996
- The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression [see comments]Blood, 1995